Vaccines based on mutant CALR and JAK2 and uses thereof
JP2025500258A5Inactive Publication Date: 2025-12-22JANSSEN BIOTECH INC
View PDF 0 Cites -1 Cited by
Patent Information
- Application Number
- JP2024536017
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-03-07
- Filing Date
- 2022-12-13
- Publication Date
- 2025-12-22
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 00000000_0000_ABST
Abstract
Disclosed herein are methods of treating or preventing a myeloproliferative disorder, cancer, or cardiovascular disease and methods of inducing an immune response in a subject with a JAK2V617F substitution and / or a CALR exon 9 mutation.
Need to check novelty before this filing date? Find Prior Art